entertainment -WSS

entertainment

author：entertainment 2025-09-28 02:47:50 - browse：536

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Fed up with FDA, ALS advocates consider a take

explore

entertainment

WSS

Baby aspirin cuts fat buildup in liver disease patients, in small study

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

FDA weighs limits of animal data in assessing artificial wombs

Midwives could help bridge maternal health disparities in the U.S.

Why the quest to eradicate polio has stumbled

PBMs drew scrutiny in House hearing — and so did pharma

leisure time

entertainment

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

App could help diagnose ear infections more accurately — and at home

Activists slam private health insurers over coverage restrictions

David Liu startup to focus on CRISPR delivery

Malaria cases in Florida and Texas: Here’s what you need to know

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Cancer drug shortages should be causing more outrage

Methadone treatment changes are coming. Do they go far enough?

Moonlake's readout produced a cash windfall. Risks remain

App could help diagnose ear infections more accurately — and at home

leisure time

Assistant physicians can help address the primary care shortage

Transgender sports debate: Physicians say bans are health issue

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Colonoscopy prep: Liquid

White House Covid adviser calls on docs to combat misinformation

Leading voice in opioid treatment defends methadone clinic system

knowledge

explore

entertainment

explore